Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rabix-IG
- Development stage
- Unknown
- Lead developer
- Incepta Pharmaceuticals
- Administration
- Intramuscular, Infiltration
01
Overview
Rabix-IG is an equine-derived rabies immunoglobulin (ERIG) developed by Incepta Vaccines for passive immunization against rabies. It consists of purified fragments of anti-rabies immunoglobulin obtained from the serum of healthy equines that have been immunized against the rabies virus. The product is indicated for post-exposure prophylaxis (PEP) in individuals who have had contact with a rabid or suspected rabid animal. By providing immediate, pre-formed antibodies, Rabix-IG neutralizes the rabies virus at the site of exposure before it can enter the central nervous system, bridging the immunity gap until the patient's own immune system produces antibodies in response to active vaccination. It is typically administered via wound infiltration and intramuscular injection.
- Brand names
- Rabix-IG
- Other names
- Rabies ImmunoglobulinEquine Rabies ImmunoglobulinERIG
02
Targets
RABV-G (Rabies virus glycoprotein)
Beyond the preview
Go deeper on Rabix-IG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rabix-IG.